Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas

NCT05663125 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT05663125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05663125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 1, 2022
Completion date
December 30, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent glioblastoma